Published in Br J Pharmacol on January 01, 2001
Peripheral chemoreceptors: function and plasticity of the carotid body. Compr Physiol (2012) 2.30
Inhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood flow and aerobic energy turnover in the exercising human leg. J Physiol (2007) 1.75
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol (2009) 1.60
Endotoxemia-induced inflammation and the effect on the human brain. Crit Care (2010) 1.02
ATP-induced vasodilation in human skeletal muscle. Br J Pharmacol (2004) 0.96
Effect of carbonic anhydrase inhibition on GFR and renal hemodynamics in adenosine-1 receptor-deficient mice. Pflugers Arch (2004) 0.92
Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures. EMBO J (2013) 0.89
Extracellular H+ induces Ca2+ signals in respiratory chemoreceptors of zebrafish. Pflugers Arch (2014) 0.80
Acetazolamide attenuates chemical-stimulated but not thermal-stimulated acute pain in mice. Acta Pharmacol Sin (2013) 0.79
Effects of acetazolamide on transient K+ currents and action potentials in nodose ganglion neurons of adult rats. CNS Neurosci Ther (2011) 0.77
Pulmonary vasodilation by acetazolamide during hypoxia: impact of methyl-group substitutions and administration route in conscious, spontaneously breathing dogs. J Appl Physiol (1985) (2014) 0.76
Increased Carbonic Anhydrase Activity is Associated with Sleep Apnea Severity and Related Hypoxemia. Sleep (2015) 0.76
The carbonic anhydrase inhibitors methazolamide and acetazolamide have different effects on the hypoxic ventilatory response in the anaesthetized cat. J Physiol (2006) 0.76
The effect of acetazolamide on different ocular vascular beds. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
The noncarbonic anhydrase inhibiting acetazolamide analog N-methylacetazolamide reduces the hypercapnic, but not hypoxic, ventilatory response. Physiol Rep (2015) 0.75
Dorzolamide-induced relaxation of isolated rabbit ciliary arteries mediated by inhibition of extracellular calcium influx. Jpn J Ophthalmol (2016) 0.75
The measurement of volume changes in human limbs. J Physiol (1953) 9.67
Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol (1995) 7.98
Regulation of arterial tone by activation of calcium-dependent potassium channels. Science (1992) 4.98
Tetraethylammonium ions and the potassium permeability of excitable cells. Rev Physiol Biochem Pharmacol (1983) 2.54
Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension (1995) 2.54
Two Ca-dependent K-channels classified by the application of tetraethylammonium distribute to smooth muscle membranes of the rabbit portal vein. Pflugers Arch (1985) 2.10
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest (1991) 1.82
Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol (1991) 1.58
Local effects of O2 and CO2 on limb, renal, and coronary vascular resistances. Am J Physiol (1967) 1.34
Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation (1995) 1.19
STUDIES ON VASOMOTOR TONE. I. THE EFFECT OF THE TETRA-ETHYLAMMONIUM ION ON THE PERIPHERAL BLOOD FLOW OF NORMAL SUBJECTS. J Clin Invest (1949) 1.12
Role of the wrist cuff in forearm plethysmography. Clin Sci (Lond) (1991) 1.09
Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension (1999) 1.06
Force, membrane potential, and [Ca2+]i during activation of rat mesenteric small arteries with norepinephrine, potassium, aluminum fluoride, and phorbol ester. Effects of changes in pHi. Circ Res (1993) 1.04
Effect of nitric oxide blockade by NG-nitro-L-arginine on cerebral blood flow response to changes in carbon dioxide tension. J Cereb Blood Flow Metab (1992) 1.00
Indomethacin abolishes cerebral blood flow increase in response to acetazolamide-induced extracellular acidosis: a mechanism for its effect on hypercapnia? J Cereb Blood Flow Metab (1993) 0.96
Carbonic anhydrase activity of the cat hind leg. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.94
The effect of acetazolamide on the retinal circulation. Eye (Lond) (1993) 0.94
Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia (1996) 0.94
The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004. J Pharmacol Exp Ther (1993) 0.92
Bradykinin mediation of Ca(2+)-activated K+ channels regulates coronary blood flow in ischemic myocardium. Circulation (1997) 0.90
Retention of carbon dioxide in tissue following carbonic anhydrase inhibition in dogs. Clin Ther (1994) 0.88
Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol (1985) (1988) 0.87
Potassium channel opening properties of thiazide diuretics in isolated guinea pig resistance arteries. J Cardiovasc Pharmacol (1994) 0.87
Organ and species differences in tissue vascular carbonic anhydrase activity. J Appl Physiol Respir Environ Exerc Physiol (1980) 0.84
Relaxation and decrease in [Ca2+]i by hydrochlorothiazide in guinea-pig isolated mesenteric arteries. Br J Pharmacol (1995) 0.82
Inhibition of carbonic anhydrase by nitric oxide. Arzneimittelforschung (1995) 0.81
Direct measurements of the rate constants of sulfonamides with carbonic anhydrase. Mol Pharmacol (1992) 0.80
Effects of hypercapnia on human forearm blood vessels. Am J Physiol (1967) 0.80
Vascular effects of acetazolamide on the choroid plexus. J Pharmacol Exp Ther (1990) 0.79
Lack of soluble carbonic anhydrase in aortic smooth muscle of the rabbit. Pflugers Arch (1985) 0.79
Cardiovascular effects of intracisternal injections of acetazolamide. Cardiovasc Res (1973) 0.78
Gastric mucosal protection by acetazolamide in rats. Roles of prostaglandins, sulfhydryls, and gastric motility. Acta Gastroenterol Latinoam (1994) 0.78
Calculation of plasma concentrations of intra-arterially infused compounds in forearm plethysmography. Cardiovasc Res (1998) 0.78
The use of tetraethylammonium in peripheral vascular disease and causalgic states; a new method for producing blockade of the autonomic ganglion. Surgery (1946) 0.77
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene (2007) 1.97
Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet (2002) 1.95
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol (1996) 1.85
Both body and arm position significantly influence blood pressure measurement. J Hum Hypertens (2003) 1.73
A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa. Health Policy Plan (2001) 1.69
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans. J Physiol (2007) 1.61
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia (2009) 1.59
The effects of caffeine on the postprandial fall of blood pressure in the elderly. Age Ageing (1988) 1.54
Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption. Eur J Clin Invest (1999) 1.53
Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects. Diabetes Care (1998) 1.52
Vein graft stenosis and the heparin responsiveness of human vascular smooth muscle cells. Circulation (1998) 1.51
Arm position is important for blood pressure measurement. J Hum Hypertens (1999) 1.50
Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities. J Hum Hypertens (2000) 1.46
Scintigraphic findings in stress fractures. J Bone Joint Surg Am (1977) 1.44
Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels? Diabetologia (1996) 1.43
Computer algorithms for the automated measurement of retinal arteriolar diameters. Br J Ophthalmol (2001) 1.42
Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J (2001) 1.42
Comparison of two indices for forearm noradrenaline release in humans. Clin Sci (Lond) (2000) 1.42
Dynamic vessel wall properties and their reproducibility in subjects with increased cardiovascular risk. J Hum Hypertens (1998) 1.40
The effect of caffeine on renal vein renin concentration in patients with renal arterial disease. Am J Hypertens (1991) 1.40
Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon. Clin Sci (Lond) (1991) 1.40
Withdrawal of antihypertensive drugs in selected patients. Lancet (1994) 1.39
[A single blood pressure reading during check-up for hypertension leads to a change in management more often than multiple readings]. Ned Tijdschr Geneeskd (1994) 1.39
Venous reflux has a limited effect on calf muscle pump dysfunction in post-thrombotic patients. Clin Sci (Lond) (2000) 1.39
[Hypertension and renal artery stenosis; a combination with a difficult diagnosis and treatment]. Ned Tijdschr Geneeskd (1996) 1.39
[No response to antihypertensive therapy: consider non-adherence]. Ned Tijdschr Geneeskd (2007) 1.39
The role of the alpha-adrenergic receptor in the leg vasoconstrictor response to orthostatic stress. Acta Physiol (Oxf) (2008) 1.39
Intravascular pressure-evoked changes in intracellular calcium [Ca2+]i and tone in rat mesenteric and rabbit cerebral arteries in vitro. J Hum Hypertens (1999) 1.39
Sodium-blood pressure interrelationship in pregnancy. J Hum Hypertens (1999) 1.38
Routine intracoronary beta-irradiation. Acute and one year outcome in patients at high risk for recurrence of stenosis. Eur Heart J (2002) 1.38
[Diagnosis and therapy of hypertension with renal artery stenosis]. Ned Tijdschr Geneeskd (1996) 1.38
Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. Clin Sci (Lond) (2002) 1.38
[Compliance with therapy: determining factors and possibilities for improvement]. Ned Tijdschr Geneeskd (1994) 1.37
Blood flow and vessel mechanics in a physiologically realistic model of a human carotid arterial bifurcation. J Biomech (2000) 1.31
Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med (1994) 1.29
Curvature and tortuosity of the superficial femoral artery: a possible risk factor for peripheral arterial disease. J Appl Physiol (1985) (2006) 1.26
Vascular network changes in the retina with age and hypertension. J Hypertens (1995) 1.25
Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia (1998) 1.20
The complete amino-acid sequence of the sweet protein thaumatin I. Eur J Biochem (1979) 1.19
Methotrexate modulates the kinetics of adenosine in humans in vivo. Ann Rheum Dis (2005) 1.18
Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. Br Med J (Clin Res Ed) (1984) 1.17
Reconstruction of blood flow patterns in a human carotid bifurcation: a combined CFD and MRI study. J Magn Reson Imaging (2000) 1.17
Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension (2000) 1.14
Serum concentrations of immunoreactive calcitonin in patients with hypergastrinaemia. Digestion (1980) 1.13
Characterization of ATP-induced vasodilation in the human forearm vascular bed. Circulation (1994) 1.13
Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun (1992) 1.13
Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther (1990) 1.12
Wave-energy patterns in carotid, brachial, and radial arteries: a noninvasive approach using wave-intensity analysis. Am J Physiol Heart Circ Physiol (2005) 1.11
The case for case reports in the Netherlands Journal of Medicine. Neth J Med (2006) 1.10
Saturable pharmacokinetics in the renal excretion of drugs. Clin Pharmacokinet (1989) 1.10
The captopril test in the detection of renovascular disease in hypertensive patients. Arch Intern Med (1990) 1.10
Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension (1998) 1.09
Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1997) 1.09
Role of the wrist cuff in forearm plethysmography. Clin Sci (Lond) (1991) 1.09
[Lavage almost never indicated after an autointoxication]. Ned Tijdschr Geneeskd (2000) 1.08
Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Diabetologia (2008) 1.07
Vascular adaptations to 8-week cycling training in older men. Acta Physiol (Oxf) (2007) 1.07
Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol (2003) 1.06
Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension (1999) 1.06
Radioenzymatic assay of plasma adrenaline and noradrenaline: evidence for a catechol-O-methyltransferase (COMT) inhibiting factor associated with essential hypertension. Clin Chim Acta (1982) 1.05
Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol (1987) 1.05
Multiple pathways of organic anion secretion in renal proximal tubule revealed by confocal microscopy. Am J Physiol (1996) 1.05
Comparison of intrabrachial and finger blood pressure in healthy elderly volunteers. Am J Hypertens (1995) 1.05
Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab (2001) 1.04
pp60c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun (1995) 1.04
Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest (2005) 1.04
Arteriolar length-diameter (L:D) ratio: a geometric parameter of the retinal vasculature diagnostic of hypertension. J Hum Hypertens (1996) 1.03
Does it matter whether blood pressure measurements are taken with subjects sitting or supine? J Hypertens (1998) 1.03
Metformin improves cardiac functional recovery after ischemia in rats. Horm Metab Res (2002) 1.03
Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest (2001) 1.02
Anaphylactoid response to intravenous acetylcysteine. Lancet (1992) 1.02
Combination of Ca2+ -activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery. Br J Pharmacol (2006) 1.02
The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro. Br J Clin Pharmacol (1987) 1.01
Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone (2001) 1.01
The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension. J Clin Pharmacol (1992) 1.01
Effect of decaffeinated versus regular coffee on blood pressure. A 12-week, double-blind trial. Hypertension (1989) 1.00
Mechanisms and clinical implications of renal drug excretion. Drug Metab Rev (2001) 0.99
Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients. J Clin Microbiol (2000) 0.98
Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med (1988) 0.98
Direct vasodilator effects of physiological hyperinsulin-aemia in human skeletal muscle. Eur J Clin Invest (1996) 0.98
Postjunctional alpha 2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels. Br J Pharmacol (1989) 0.98